Richard Auran, MD
Orthopaedic Surgery · Portland, ORNPI 1093246944
Payments from drug & device makers
What this record shows
This record is dominated by education: $13,134 of the $21,781 with a category attached, or 60.3%. Smith+Nephew accounts for 72.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $8,698 and has fallen 98.5% since, to $132 in 2025.
Across 78 payments — averaging $279.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$16K
- Medical Device Business Services, Inc.$2K
- Stryker$2K
- Johnson & Johnson$1K
- Zimmer Biomet$632
- Xtant Medical Inc$301
- plus $674 from 7 others
What the payments were for
- Grants$3,75017%
- Travel & lodging$2661%
- Food & beverage$4,63121%
- Education$13,13460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 9 | $15,804 |
| Medical Device Business Services, Inc. | 14 | $1,740 |
| Stryker | 21 | $1,586 |
| Johnson & Johnson | 11 | $1,044 |
| Zimmer Biomet | 9 | $632 |
| Xtant Medical Inc | 5 | $301 |
| Orthofix Medical, Inc. | 3 | $192 |
| Goode Surgical Inc | 1 | $118 |
| Globus Medical | 1 | $113 |
| Terumo BCT, Inc. | 1 | $110 |
| Impactortho, Inc. | 1 | $91 |
| Vertex | 1 | $29 |
| Steelhead Surgical Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,781 in reported general payments places this provider in the 85th percentile of 228 orthopaedic surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 54 | $801 |
| Oxycodone Hcl | 99 | $724 |
| Meloxicam | 96 | $361 |
| Ondansetron Hcl | 28 | $204 |
| Celecoxib | 19 | $200 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $177 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Portland
- Michelle WelbornPortland$364K
- Elizabeth LiebermanPortland$353K
- Jonathan SalesPortland$303K
- James HaydenPortland$264K
- Paul DuweliusPortland$144K
- Stefan TarlowPortland$134K
- Jay ButlerPortland$98K
- John AndersonPortland$43K
- Jeremy BauerPortland$40K
- David PutnamPortland$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.